Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure

被引:5
|
作者
Gimenez-Escamilla, Isaac [1 ,2 ]
Benedicto, Carlota [1 ]
Perez-Carrillo, Lorena [1 ,2 ]
Delgado-Arija, Marta [1 ,2 ]
Gonzalez-Torrent, Irene [1 ]
Vilchez, Roger [3 ,4 ]
Martinez-Dolz, Luis [1 ,2 ,5 ]
Portoles, Manuel [1 ,2 ]
Tarazon, Estefania [1 ,2 ]
Rosello-Lleti, Esther [1 ,2 ]
机构
[1] Hlth Res Inst Hosp La Fe IIS La Fe, Clin & Translat Res Cardiol Unit, Avd Fernando Abril Martorell 106, Valencia 46026, Spain
[2] Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Avd Monforte Lemos 3-5, Madrid 28029, Spain
[3] Hlth Res Inst Hosp La Fe IIS La Fe, Neuromuscular & Ataxias Res Grp, Avd Fernando Abril Martorell 106, Valencia 46026, Spain
[4] Ctr Biomed Network Res Rare Dis CIBERER, Avd Monforte Lemos 3-5, Madrid 28029, Spain
[5] Univ & Polytech La Fe Hosp, Cardiol Dept, Heart Failure & Transplantat Unit, Avd Fernando Abril Martorell 106, Valencia 46026, Spain
关键词
mitochondria; heart failure; ischemic and dilated cardiomyopathy; OXPHOS; complex V; cardiac remodeling; GENE-EXPRESSION; MECHANISMS; GENERATION; GUIDELINES; TRANSPORT; REVEALS; STRESS;
D O I
10.3390/antiox13030285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heart failure (HF) is a disease related to bioenergetic mitochondrial abnormalities. However, the whole status of molecules involved in the oxidative phosphorylation system (OXPHOS) is unknown. Therefore, we analyzed the OXPHOS transcriptome of human cardiac tissue by RNA-seq analyses (mRNA n = 36; ncRNA n = 30) in HF patients (ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM)) and control subjects. We detected 28 altered genes in these patients, highlighting greater deregulation in ICM. Specifically, we found a general overexpression of complex V (ATP synthase) elements, among them, ATP5I (ICM, FC = 2.04; p < 0.01), ATP5MJ (ICM, FC = 1.33, p < 0.05), and ATP5IF1 (ICM, FC = 1.81; p < 0.001), which presented a significant correlation with established echocardiographic parameters of cardiac remodeling and ventricular function as follows: left ventricular end-systolic (p < 0.01) and end-diastolic (p < 0.01) diameters, and ejection fraction (p < 0.05). We also detected an increase in ATP5IF1 protein levels (ICM, FC = 1.75; p < 0.01) and alterations in the microRNA expression levels of miR-208b-3p (ICM, FC = -1.44, p < 0.001), miR-483-3p (ICM, FC = 1.37, p < 0.01), regulators of ATP5I. Therefore, we observed the deregulation of the OXPHOS transcriptome in ICM patients, highlighting the overexpression of complex V and its relationship with cardiac remodeling and function.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction
    Stride, Nis
    Larsen, Steen
    Hey-Mogensen, Martin
    Sander, Kare
    Lund, Jens T.
    Gustafsson, Finn
    Kober, Lars
    Dela, Flemming
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (02) : 150 - 157
  • [2] Alterations in mitochondrial function in cardiac hypertrophy and heart failure
    Osterholt, Moritz
    Nguyen, T. Dung
    Schwarzer, Michael
    Doenst, Torsten
    HEART FAILURE REVIEWS, 2013, 18 (05) : 645 - 656
  • [3] Alterations in mitochondrial function in cardiac hypertrophy and heart failure
    Moritz Osterholt
    T. Dung Nguyen
    Michael Schwarzer
    Torsten Doenst
    Heart Failure Reviews, 2013, 18 : 645 - 656
  • [4] Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation
    Rosca, Mariana G.
    Vazquez, Edwin J.
    Kerner, Janos
    Parland, William
    Chandler, Margaret P.
    Stanley, William
    Sabbah, Hani N.
    Hoppel, Charles L.
    CARDIOVASCULAR RESEARCH, 2008, 80 (01) : 30 - 39
  • [5] Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure
    Bhullar, Sukhwinder K.
    Dhalla, Naranjan S.
    ANTIOXIDANTS, 2023, 12 (11)
  • [6] Diseases of the human mitochondrial oxidative phosphorylation system
    Ruiz-Pesini, E.
    Lopez-Gallardo, E.
    Dahmani, Y.
    Herrero, M. D.
    Solano, A.
    Diez-Sanchez, C.
    Lopez-Perez, M.
    Montoya, J.
    REVISTA DE NEUROLOGIA, 2006, 43 (07) : 416 - 424
  • [7] Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure
    Pellicori, Pierpaolo
    Cleland, John G. F.
    Zhang, Jufen
    Kallvikbacka-Bennett, Anna
    Urbinati, Alessia
    Shah, Parin
    Kazmi, Syed
    Clark, Andrew L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (06) : 599 - 609
  • [8] Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart
    Lemieux, Helene
    Semsroth, Severin
    Antretter, Hervvig
    Hoefer, Daniel
    Gnaiger, Erich
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (12) : 1729 - 1738
  • [9] Mitochondrial dysfunction and calcium homeostasis in heart failure: Exploring the interplay between oxidative stress and cardiac remodeling for future therapeutic innovations
    Johnson, Emily
    Albakri, Jameela Shukri
    Allemailem, Khaled S.
    Sultan, Abdulaziz
    Alwanian, Wanian M.
    Alrumaihi, Faris
    Almansour, Nahlah Makki
    Aldakheel, Fahad M.
    Khalil, Fatma Mohamed Ameen
    Abduallah, Alduwish Manal
    Smith, Oliver
    CURRENT PROBLEMS IN CARDIOLOGY, 2025, 50 (03) : 102968
  • [10] Linoleic acid improves assembly of the CII subunit and CIII2/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure
    Maekawa, Satoshi
    Takada, Shingo
    Nambu, Hideo
    Furihata, Takaaki
    Kakutani, Naoya
    Setoyama, Daiki
    Ueyanagi, Yasushi
    Kang, Dongchon
    Sabe, Hisataka
    Kinugawa, Shintaro
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)